Statins —the well-known inhibitors of endogenous cholesterol biosynthesis [36]—reduce the growth of Brain Tumor Initiating Cells (BTICs), where mevalonate pathway genes, including FDPS, are strongly upregulated, through a feed-forward loop between c-Myc and the mevalonate pathway [37]. The gene discussed is MYC; the disease is brain neoplasm.